Company intelligence / Profile preview

BioSpherix

Parish, New York, United Statesbiospherix.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

BioSpherix develops and manufactures advanced modular systems for physiologic cell and tissue culture environments. Their flagship Xvivo System® enables aseptic, uninterrupted workflows with precise gas control, supporting reproducible research and GMP-compliant manufacturing in academic labs, biotech/pharma R&D, and clinical production settings. The company’s solutions are widely used in regenerative medicine, stem cell research, cellular agriculture, bioprocessing development, and gene/cell therapy manufacturing.

Modalities: Device (cell culture systems, incubators, isolators)
Industry: Non-Drug Biotech

Partnerships

Academic institutions/labs globally as customers/usersNo major disclosed pharma/biotech partnerships found.

Beyond the preview

Go deeper on BioSpherix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSpherix.

Explore the full profile